Home Research Protocols 2005009

2005009

A pilot clinical trial to determine the potentials of a 3-day, 200 mg 6 hourly course of Rifaximin by comparing its efficacy with that of a 3-day, 500 mg 12 hourly dose of ciprofloxacin in the treatment of adults with clinically severe cholera due to V. cholerae O1 or O139.
Short Title Rifaximin therapy for severe cholera in adults.
Protocol No 2005009
Status Completed
Keywords ANTIMICROBIAL THERAPY, BANGLADESH, CIPROFLOXACIN, CHOLERA, RIFAXIMIN, V. CHOLERAE O1, V. CHOLERAE O139
Center Clinical Sciences
MDG(s) this protocol relates to
HPNSDP(s) this protocol relates to
PI Name Md Abdus Salam
Collaborating Institutes (109) Salix Pharmaceuticals
Funding
Summary
‹ Search All Protocols Here

Highlights